<head>
<!-- Stylesheet -->
<link rel="stylesheet" href="css/video.css">
</head>
<main id="video">
  <div id="shader"></div>
    <h2 class="primary">Video Channel</h2>
    <div class="video-container">
      <video
      id="my-video"
      class="video-js vjs-big-play-centered vjs-fluid"
      controls
      preload="auto"
      poster="assets/images/video/thumbnail.png"
      data-setup="{}"
    >
      <source src="assets/images/video/Beleodaq-KOL-video-v5.mp4" type="video/mp4" />
      
      <p class="vjs-no-js">
        To view this video please enable JavaScript, and consider upgrading to a
        web browser that
        <a href="https://videojs.com/html5-video-support/" target="_blank"
        >supports HTML5 video</a
        >
      </p>
    </video>
    <a class="video-close" href="#">
      <i class="fas fa-times"></i>
    </a>
  </div>
    <div class="info">
        <img src="assets/images/video/video-thumbnail.png" alt="Woman smiling">
        <div>
            <h3 class="secondary-variant extrabold">PTCL is aggressive.<br>
            Be ready with BELEODAQ at Ô¨Årst relapse.</h3>
            <p>Watch Dr. Xavier discuss the aggressive nature of nodal peripheral T-cell lymphoma (PTCL) subtypes and review key data from the BELIEF trial.</p>
            <button class="video-btn">
                <i class="fas fa-play fa-lg"></i>
                WATCH THE FULL VIDEO</button>
            <p>Intended for HCPs</p>
        </div>
    </div>
    <div class="button-group">
        <a href="" ui-sref="ACCESS" class="button secondary"><i class="fas fa-chevron-left"></i> Access &amp; Resources</a>
        <a href="" ui-sref="CONTACT" class="button">Contact Us<i class="fas fa-chevron-right"></i></a>
    </div>
</main>
<script src="js/video-listener.js"></script>
<script src="https://vjs.zencdn.net/7.17.0/video.min.js"></script>

